Keyphrases
Acute Coronary Syndrome
6%
Acute Decompensated Heart Failure
18%
Acute Myocardial Infarction
13%
Apoptosis
9%
Arrhythmia
9%
Aspirin
7%
Atrial Fibrillation
7%
Autophagy
12%
Ca2+
10%
Cardiac Dysfunction
6%
Cardiac Function
19%
Cardiac Hypertrophy
13%
Cardiac Remodeling
12%
Cardiomyocytes
23%
Cardiomyopathy
9%
Cardioprotection
7%
Cardiovascular Disease
14%
Cardiovascular Risk
7%
Caveolin-1 (Cav-1)
10%
Channel Subunits
8%
Chronic Heart Failure
7%
Clinical Outcomes
6%
Clinical Trials
8%
Confidence Interval
13%
Congestive Heart Failure
8%
Coronary Artery Disease
18%
COVID-19
9%
Diabetes
10%
Diastole
9%
Diastolic Filling
11%
Diastolic Function
24%
Dilated Cardiomyopathy
10%
Disease Progression
6%
Dominant Negative
6%
Doppler Velocity
6%
E Wave
20%
Echocardiographic
13%
Echocardiography
8%
Ejection Fraction
7%
Failing Heart
12%
Gene Expression
13%
Gene-deficient Mice
7%
Genotype
6%
Hazard Ratio
9%
Heart Failure
91%
Heart Failure Patients
12%
Heart Failure with Preserved Ejection Fraction (HFpEF)
21%
High Risk
6%
Human Heart
11%
Hypertrophic Cardiomyopathy
7%
Hypertrophy
7%
Inflammation
18%
Inflammatory Cytokines
7%
Insulin Resistance
8%
Interleukin-1β
9%
Ischemia-reperfusion Injury
11%
K Channels
6%
K+ Current
17%
Kv4.2
12%
Left Ventricle
10%
Left Ventricular Assist Device
9%
Left Ventricular Dysfunction
9%
Left Ventricular Ejection Fraction
13%
Left Ventricular End-diastolic Pressure
9%
Left Ventricular Function
37%
Left Ventricular Remodeling
13%
Macrophages
31%
Mitochondria
6%
Model Prediction
6%
Molecular Mechanism
8%
Mouse Heart
7%
Mouse Model
12%
Murine Model
7%
Myocardial Infarction
25%
Myocardium
24%
Myocytes
27%
Obesity
11%
Overexpression
14%
Pathophysiology
6%
Patients with Heart Failure
20%
Peroxisome Proliferator-activated Receptor
12%
Physiologic
6%
Placebo
6%
Positron Emission Tomography
7%
Pressure Overload
7%
Protein Kinase
6%
Stiffness
7%
TNF Receptor 1 (TNFR1)
9%
Transcription Factor
7%
Transcription Factor EB
6%
Transgenic Mice
13%
Transmitral
9%
Transmitral Flow
10%
Tumor Necrosis Factor-α
34%
Type 2 Diabetes Mellitus (T2DM)
7%
Ventricular Arrhythmia
7%
Ventricular Assist Device
6%
Voltage Gating
7%
Voltage-gated K+ Channels
7%
Warfarin
7%
Medicine and Dentistry
Action Potential
5%
Acute Heart Infarction
6%
Adrenergic Receptor
5%
Assisted Circulation
8%
Atherosclerosis
8%
Atrial Fibrillation
6%
Biological Marker
5%
Calcium Ion
10%
Cardiac Dysrhythmia
7%
Cardiac Fibrosis
6%
Cardiac Muscle Cell
26%
Cardiovascular Disease
11%
Cardiovascular System
18%
Clinical Trial
8%
Congestive Heart Failure
100%
Coronary Artery Disease
8%
COVID-19
6%
Cytokine
8%
Diabetes
10%
Diabetes Mellitus
9%
Diastolic Function
21%
Dilated Cardiomyopathy
6%
Diseases
22%
Echocardiography
10%
Ejection Fraction
11%
Endothelial Cell
5%
Exercise
8%
Fatty Acid
6%
Fibroblast
5%
Fibrosis
5%
Gene Expression
8%
Heart Disease
6%
Heart Failure with Preserved Ejection Fraction
8%
Heart Failure with Reduced Ejection Fraction
6%
Heart Function
13%
Heart Graft
7%
Heart Left Ventricle Ejection Fraction
9%
Heart Left Ventricle Failure
6%
Heart Left Ventricle Function
5%
Heart Muscle Ischemia
7%
Heart Muscle Metabolism
5%
Heart Transplantation
6%
Heart Ventricle Function
6%
Heart Ventricle Remodeling
18%
Hemodynamic
13%
Homeostasis
6%
Hypertrophic Cardiomyopathy
5%
In Vitro
6%
Infarction
8%
Infection
5%
Insulin Resistance
6%
Ischemic Heart Disease
6%
Isotopes of Calcium
5%
Left Ventricle
8%
Left Ventricular Assist Device
11%
Lung
8%
Macrophage
18%
Messenger RNA
8%
Mitral Valve
5%
Muscle Contractility
5%
Myocardial Disease
10%
Myocardial Infarction
12%
Myocardium
17%
Oxygen Consumption
5%
Placebo
5%
Positron Emission Tomography
5%
Potassium Current
11%
Programmed Cell Death
5%
Quality of Life
5%
Receptor
5%
Systolic Function
6%
Transgenic Mouse
7%
Transplantation
6%
Tumor Necrosis Factor
19%
Ventricle of Heart
5%
Ventricular Assist Device
7%
Ventricular Hypertrophy
13%
Biochemistry, Genetics and Molecular Biology
Action Potential
11%
Adrenergic Receptor
5%
Allele
7%
Animal Model
6%
Atrial Fibrillation
5%
Autophagy
14%
Blood Plasma
9%
Cardiac Dysrhythmia
10%
Cardiac Muscle Cell
48%
Caveolin 1
9%
Cell Death
8%
Cytokine
6%
Electric Potential
12%
Exome Sequencing
5%
Fibroblast
5%
Gene Expression
17%
Genetic Divergence
5%
Genetics
12%
Genomics
7%
Genotyping
9%
Heart Ejection Fraction
12%
Heart Function
10%
Heart Ventricle Function
5%
Hemodynamic
7%
Homeostasis
7%
Ion Channel
8%
Kinase
8%
Knockout Mouse
8%
Lipid
9%
Lysosome
7%
Macrophage
19%
Messenger RNA
7%
Metabolic Pathway
8%
Mitochondrion
6%
Mouse Model
8%
N-Terminus
7%
Peroxisome Proliferator-Activated Receptor
9%
Phosphotransferase
8%
Potassium Channel
9%
Potassium Current
21%
Programmed Cell Death
10%
Promoter Region
7%
Proteomics
6%
Reperfusion
10%
Repolarization
7%
Rigidity
7%
Single-Nucleotide Polymorphism
5%
Stem Cell
6%
Transcription Factors
9%
Transgenic Mouse
11%
Tumor Necrosis Factor
16%
Upregulation
6%
Wild Type
11%